Skip to main content

Peer Review reports

From: RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer

Original Submission
28 Feb 2020 Submitted Original manuscript
21 Mar 2020 Reviewed Reviewer Report
5 Apr 2020 Reviewed Reviewer Report
30 Jul 2020 Author responded Author comments - John Tentler
Resubmission - Version 2
30 Jul 2020 Submitted Manuscript version 2
6 Aug 2020 Reviewed Reviewer Report
25 Aug 2020 Reviewed Reviewer Report
2 Sep 2020 Author responded Author comments - John Tentler
Resubmission - Version 3
2 Sep 2020 Submitted Manuscript version 3
4 Oct 2020 Author responded Author comments - John Tentler
Resubmission - Version 4
4 Oct 2020 Submitted Manuscript version 4
Publishing
6 Oct 2020 Editorially accepted
4 Nov 2020 Article published 10.1186/s12885-020-07500-1

You can find further information about peer review here.

Back to article page